India Respiratory Care Devices Market, By Product Type (Therapeutic Devices, Monitoring Devices, Diagnostic Devices, Consumables & Accessories), By Indication (Chronic Obstructive Pulmonary Disease, Infectious Diseases, Asthma, Sleep Apnea, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competition, Opportunities and Forecast, 2020-2030F

Market Overview

India Respiratory Care Devices Market was valued at USD 1.50 billion in 2024 and is anticipated to reach USD 2.27 Billion by 2030, with a CAGR of 7.07% during 2025-2030. 

Respiratory care devices are medical tools designed to help individuals breathe more effectively, enhance lung function, and manage respiratory disorders. Used across hospitals, home healthcare, and personal settings, they serve diagnostic, therapeutic, and supportive roles. Ventilators assist patients who cannot breathe adequately on their own by delivering controlled air or oxygen, supporting cases of respiratory failure. Nebulizers convert liquid medication into a fine mist for inhalation, commonly used in conditions like asthma, COPD, and cystic fibrosis. Pulse oximeters non-invasively measure blood oxygen levels and pulse rate, enabling continuous monitoring.

In India, rising air pollution levels in urban areas have significantly increased respiratory illnesses, making these devices essential. Technological advancements, including efficient ventilators, oxygen concentrators, and portable solutions, are driving adoption. Additionally, growing awareness of respiratory health, early diagnosis, and the impact of environmental factors like pollution and allergens continues to boost demand for monitoring and treatment devices.

Key Market Drivers

Technological Advancements

Technological advancements are significantly improving the performance and reach of respiratory care devices in India by making diagnosis more data-driven, therapy more personalized, and long-term disease management more accessible across hospitals, clinics, and home settings. Ventilator technology has evolved beyond basic mechanical support to include pressure, volume, and adaptive modes that allow clinicians to better tailor treatment to individual respiratory needs, while newer devices are also becoming more modular, cost-efficient, and suitable for both adult and pediatric patients.

At the same time, respiratory care is becoming more connected through smart inhalers, adherence-monitoring systems, AI-enabled screening tools, and digitally supported CPAP therapy that improve patient compliance and help physicians intervene earlier. Portable oxygen concentrators, quieter PAP devices, remote monitoring platforms, and emerging technologies such as nanotechnology, breath sensors, and 3D printing are also broadening the use of respiratory devices beyond intensive care into everyday chronic care management. For Instance, the Technology Development Board approved ₹3.94 crore in 2023 for Noccarc Robotics out of a total project cost of ₹7.89 crore to commercialize digitally enabled advanced universal ICU ventilators, highlighting how institutional backing is supporting indigenous innovation and wider access to advanced respiratory technology in India.

Increasing Aging Population

India’s rapidly aging population is becoming a major structural demand driver for respiratory care devices, because advancing age reduces lung elasticity, weakens respiratory muscles, and increases vulnerability to chronic conditions such as COPD, asthma, sleep apnea, and infection-related breathing complications that require sustained device-assisted management. This demographic shift carries particularly strong implications for oxygen concentrators, nebulizers, ventilators, and CPAP systems, since elderly patients often live with multiple coexisting conditions such as diabetes, hypertension, or heart disease that intensify respiratory distress and make long-term monitoring and support more essential.

The trend is also reshaping the care setting, as more seniors and caregivers prefer home-based treatment where portable, easy-to-use respiratory devices can reduce repeated hospital visits and improve quality of life through more continuous symptom management. Demand is likely to strengthen further as India’s senior population expands sharply and age-related sleep and breathing disorders gain more clinical attention, even though affordability and insurance limitations still restrict full access for many households. For Instance, UNFPA states that India’s elderly population is projected to rise from 153 million to 347 million by 2050, while ResMed estimates that about 104 million Indians of working age may already be living with obstructive sleep apnea, underlining the widening patient base for respiratory support devices across age groups.

Rising Environmental Factors

Rising environmental factors are becoming a major demand driver for respiratory care devices in India, as worsening air pollution, climate-linked respiratory stress, and growing exposure to allergens are increasing the burden of asthma, COPD, allergic airway disease, and other breathing complications across both urban and semi-urban populations. Pollutants such as PM2.5, ozone, and nitrogen dioxide are especially concerning because they aggravate chronic respiratory disorders and trigger acute episodes that require timely support through nebulizers, inhalers, oxygen therapy devices, and other respiratory care technologies.

The problem is compounded by environmental allergens such as pollen, mold, pet dander, and dust mites, while indoor pollution from poor ventilation, smoke, and household particulates is also widening the need for home-based respiratory support and air quality management. Climate change, heatwaves, wildfires, dust events, and occupational exposure to chemicals and industrial emissions are further intensifying the need for preventive and therapeutic respiratory solutions across regions with different environmental risk profiles. For Instance, the Centre for Research on Energy and Clean Air reported that in January 2025 only 22 Indian cities recorded good air quality, while Byrnihat averaged PM2.5 at 214 micrograms per cubic metre and Delhi at 165 micrograms per cubic metre, and the Air Quality Life Index noted that 544.4 million people in the northern plains are exposed to hazardous air.

Download Free Sample Report

Key Market Challenges

Supply Chain Issues

Supply chain issues remain a meaningful restraint on the India respiratory care device market because many products depend on globally sourced components and materials, making manufacturers vulnerable to trade disruptions, freight delays, and sudden shortages that can slow production and delivery timelines. Within India, the challenge extends beyond imports to include logistics, warehousing, inventory planning, and last-mile distribution, all of which are critical for ensuring that ventilators, oxygen concentrators, nebulizers, and related devices reach hospitals and clinics when demand rises.

The problem is intensified by the country’s fragmented medical device distribution structure, since nationwide coverage is limited and many suppliers still have deeper reach only in metros and tier 1 and tier 2 cities, which can delay availability in smaller urban and rural markets. Supply chain inefficiencies also create compliance and cost pressures, because respiratory devices must maintain quality and regulatory standards across multiple intermediaries while manufacturers try to avoid both expensive overstocking and dangerous understocking. For Instance, AMTZ estimates cited by ThePrint noted in April 2026 that disruptions linked to West Asia were affecting 30 percent to 40 percent of global trade routes in the region, increasing Indian medical device costs by 10 percent to 50 percent and lengthening lead times for ventilator and oxygen concentrator components by 20 percent to 30 percent.

Insurance and Reimbursement

In India, many individuals, particularly in lower-income segments, do not have adequate health insurance coverage. This limits their ability to afford respiratory care devices, which can be expensive. As a result, some patients may not have access to necessary devices. Even when individuals have health insurance, the coverage for respiratory care devices may be incomplete or have restrictions. Insurance plans may not fully cover the cost of devices, leaving patients with out-of-pocket expenses. Different insurance providers may have varying policies on the coverage of respiratory care devices.

This can lead to confusion and inconsistencies in reimbursement, making it challenging for patients to understand what is covered. Some insurance plans may require pre-authorization or extensive documentation before approving reimbursement for respiratory care devices. This can be time-consuming and burdensome for patients and healthcare providers. Many patients and healthcare providers may not be fully aware of the extent of insurance coverage available for respiratory care devices. This lack of awareness can result in missed opportunities for reimbursement. Accurate and detailed documentation is often required to secure reimbursement. Incomplete or incorrect documentation can result in claim denials and delayed reimbursement.

Key Market Trends

Home Healthcare

Home healthcare provides patients with the convenience of receiving respiratory care in the comfort of their homes. Patients no longer need to travel to healthcare facilities for routine check-ups, device monitoring, or treatment. Home healthcare can be a cost-effective alternative to hospital or clinic-based care. It eliminates the need for extended hospital stays and reduces healthcare expenditures for patients and insurers. India has a growing elderly population, and many older adults prefer to age in place. Home healthcare allows elderly individuals with respiratory conditions to receive care while maintaining their independence.

Many respiratory conditions, such as COPD and sleep apnea, require ongoing management and monitoring. Home healthcare offers a seamless way to address the long-term needs of patients. Advances in telemedicine and remote monitoring technology enable healthcare providers to monitor patients' respiratory health in real-time. This technology is increasingly integrated into respiratory care devices, allowing for remote data transmission.

Home-based ventilators and related respiratory care devices make it possible for ventilator-dependent patients to receive care at home. This can improve their quality of life and reduce the burden on healthcare facilities. Home healthcare providers can tailor care plans to the specific needs of patients, providing personalized care and education about respiratory conditions and device use.

Segmental Insights

Product Type Insights

In 2024, the India Respiratory Care Devices Market largest share was held by Diagnostic Devices segment and is predicted to continue expanding over the coming years. Diagnostic devices play a crucial role in the early diagnosis and continuous monitoring of respiratory conditions. Timely identification of respiratory issues is essential for effective treatment. As a result, the demand for diagnostic devices in the Indian healthcare system has been steadily increasing. Respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea have a significant prevalence in India.

To manage these conditions, healthcare providers rely on diagnostic devices such as spirometers, peak flow meters, and pulse oximeters to assess lung function and oxygen saturation levels. There has been a growing awareness among the general population and healthcare professionals about the importance of early diagnosis and regular monitoring of respiratory conditions.

This awareness has increased the adoption of diagnostic devices. Various government healthcare initiatives and programs have emphasized the importance of diagnosing respiratory conditions at an early stage. These programs have often included the procurement and distribution of diagnostic devices to healthcare facilities. The presence of specialized clinics and pulmonologists who focus on respiratory health and diseases has driven the demand for diagnostic devices. These healthcare providers rely on accurate diagnostic tools to assess and manage patients with respiratory conditions.

End-User Insights

In 2024, the India Respiratory Care Devices Market largest share was held by Hospitals & Clinics segment in the forecast period and is predicted to continue expanding over the coming years.  Hospitals and clinics in India are equipped with advanced medical infrastructure and facilities. They often have specialized respiratory care units, intensive care units (ICUs), and pulmonary departments. These facilities require a wide range of respiratory care devices to treat patients with various respiratory conditions. Hospitals and clinics serve as central locations for diagnosing and treating patients with respiratory issues.

They are equipped to provide comprehensive care, which includes the use of various respiratory care devices such as ventilators, oxygen concentrators, and nebulizers. Respiratory care devices are essential for patients in critical condition. Hospitals and clinics often treat individuals with severe respiratory diseases, such as acute respiratory distress syndrome (ARDS) or patients in need of surgery. These conditions require the use of ventilators and other advanced respiratory devices.

Hospitals and clinics have a team of healthcare professionals, including pulmonologists, respiratory therapists, and critical care nurses, who are trained to operate and manage respiratory care devices. This expertise ensures proper usage and patient care. Hospitals and clinics require a broad range of respiratory care devices to meet the diverse needs of patients. This includes devices for asthma management, sleep apnea treatment, oxygen therapy, and mechanical ventilation, among others.

Download Free Sample Report

Regional Insights

The North India region dominated the India Respiratory Care Devices Market in 2024. Higher population density can lead to a higher prevalence of respiratory diseases due to factors like air pollution, dust, and crowded living conditions. This increased disease burden drives the demand for respiratory care devices. West India, has a relatively better-developed healthcare infrastructure compared to some other regions. Well-established hospitals, clinics, and healthcare facilities are more likely to have advanced respiratory care equipment, leading to higher usage and market presence. The region is home to some of India's top government and private hospitals and medical institutions. These institutions often have access to greater resources and investments in medical equipment, including respiratory care devices. The region is home to several medical colleges and research institutions. This concentration of healthcare education and research can lead to greater awareness and utilization of advanced medical technologies, including respiratory care devices.

Recent Developments

• In March 2026, AeroDel signed an exclusive licensing arrangement with Zydus Lifesciences for the pan-India commercial launch of its A202 device as Aerolife Mini.The product was presented as India’s first foldable, “always attached” next-generation pMDI enhancer, developed to reduce inhaler-use errors and improve portability and adherence for asthma and COPD patients. This was a clear collaboration-plus-innovation milestone because it combined AeroDel’s device design and manufacturing capability with Zydus’s commercialization reach to scale a differentiated respiratory drug-device solution nationally.

• In February 2026, Zydus Lifesciences launched PEPAIR, described as India’s first affordable, drug-free Oscillating Positive Expiratory Pressure device for patients with COPD, asthma, and bronchiectasis. The handheld device was introduced in agreement with AeroDel Technology Innovations and was designed with a three-resistance system to support mucus clearance, ease congestion, and improve breathing. The launch was important because it expanded the Indian respiratory device landscape beyond inhalers and ventilators into affordable pulmonary rehabilitation and airway-clearance technology for chronic-care patients.

• In March 2025, Aerogen opened its India headquarters in New Delhi to expand access to its acute-care aerosol drug delivery technologies in the country. The office was inaugurated during the visit of Ireland’s Minister for Higher Education, Research, and Innovation, and Aerogen said the facility would serve as the operational hub for commercial, marketing, and clinical teams in India. The move stood out as a strategic collaboration-and-expansion development because the company linked the investment directly to improving access to advanced respiratory treatment solutions in India’s growing healthcare market.

• In January 2025, ResMed launched AirSense 11 in India, introducing its next-generation CPAP device for people with obstructive sleep apnea. The company said the system includes Personal Therapy Assistant, Care Check-In, remote software updates, the myAir patient app, and the AirView clinician platform to improve onboarding, adherence, and connected care. This was a notable innovation-led launch because it brought a more digital and remotely monitored respiratory support platform into the Indian sleep and home respiratory care market.

Key Market Players

• India Medtronic Private Limited
• ResMed India Pvt. Ltd.
• Koninklijke Philips N.V.
• Masimo Corp
• Getinge Medical India Pvt. Ltd.
• Drägerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare India Pvt Ltd
• Wipro GE Healthcare Pvt Ltd
• Hill-Rom India Private, Ltd.
• Becton, Dickinson and Company
• Opto Circuits India Ltd.
• Omron Healthcare India Pvt. Ltd.
• Nihon Kohden

Report Scope:

In this report, the India Respiratory Care Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Respiratory Care Devices Market, By Product Type:

o   Therapeutic Devices

o   Monitoring Devices

o   Diagnostic Devices

o   Consumables & Accessories

• India Respiratory Care Devices Market, By Indication:

o   Chronic Obstructive Pulmonary Disease

o   Infectious Diseases

o   Asthma

o   Sleep Apnea

o   Others

• India Respiratory Care Devices Market, By End-User:

o   Hospitals & Clinics

o   Ambulatory Care Centers

o   Others

• India Respiratory Care Devices Market, By Region:

o   North India

o   South India

o   East India

o   West India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the India Respiratory Care Devices Market.

Available Customizations:

India Respiratory Care Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India Respiratory Care Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]